Home Overview Press Room Blog Publications For Students about us
Search

Biotech & Pharma : Displaying 744-753 of 1742


Supreme Court Hears Gene Patent Case; Activists Rally on Courthouse Stepsby Pete ShanksBiopolitical TimesApril 18th, 2013The justices heard arguments in the Myriad gene patent case, and seemed critical of the patents but perhaps unwilling to make a broad ruling.
Can Human Genes Be Patented?by Eliot MarshallScienceApril 17th, 2013The question has been debated for years but not addressed directly by the U.S. Supreme Court—until this week. The decision, expected later this year and from which there is no appeal, could have an impact on hundreds of companies and thousands of researchers.
Which Comes First: The Woman or Her Eggs? [Quotes CGS's Marcy Darnovsky]by Ruha BenjaminHuffington PostApril 17th, 2013If we're going to support a "right to stem cell research," then we need to guarantee a right to health in the form of serious investment in egg donor safety.
Synthetic Biology as Public Relationsby Pete ShanksBiopolitical TimesApril 17th, 2013Recent synthetic biology projects related to malaria, flu and conservation are providing PR cover for the field and its corporate sponsors.
Synthetic Biologists and Conservationists Open Talksby Ewen CallawayNatureApril 16th, 2013But worries persist about unintended consequences of tinkering with nature.
Panel Discusses the Legality of Patenting Human Genes [VIDEO][With CGS's Marcy Darnovsky] China Central TelevisionApril 16th, 2013Discussion of the Supreme Court hearing on human gene patents with intellectual property attorney Geoffrey Karny and CGS's Marcy Darnovsky, hosted by Mike Walter.
Supreme Court Critical of Patents on Human Genesby David G. SavageLos Angeles TimesApril 15th, 2013The justices were highly skeptical of the idea that a company or a scientist can hold a patent on human genes and prevent others from testing or using them.
New “Semisynthetic” Anti-Malarial Drug is Unneeded and Sets Dangerous Precedent While Threatening Farmer Livelihoods[Press Release]SynBioWatchApril 15th, 2013A pharmaceutical giant announced that it will replace the entire world supply of the preferred anti-malarial treatment with a semi-synthetic product produced using synthetic biology - a controversial, unregulated biotechnology.
Egg Freezing: WTF?*[Op-Ed]by Lynn M. Morgan and Janelle S. TaylorThe Feminist WireApril 14th, 2013Egg freezing is invasive, dangerous, unregulated, and insanely expensive. Worse, it isn’t a social solution, so it cannot address the social causes that make it so difficult to balance career and family.
IVF And The Legacy Of Its Inventors[Quotes CGS's Marcy Darnovsky]by John FarrellForbesApril 12th, 201335 years after Robert G. Edwards co-developed in-vitro fertilization, the assisted reproduction industry in the US remains controversial.
Displaying 744-753 of 1742  
< Prev  Next >> 
« First Page Last Page » 
« Show Complete List » 


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1936 University Ave, Suite 350, Berkeley, CA 94704 • • (p) 1.510.665.7760 • (F) 1.510.665.8760